- Home
- NVCR vs APGE Comparison
NVCR vs APGE Comparison
Compare NVCR & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- APGE
- Stock Information
- Founded
- NVCR 2000
- APGE 2022
- Country
- NVCR Switzerland
- APGE United States
- Employees
- NVCR N/A
- APGE N/A
- Industry
- NVCR Medical/Dental Instruments
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NVCR Health Care
- APGE Health Care
- Exchange
- NVCR Nasdaq
- APGE Nasdaq
- Market Cap
- NVCR 1.9B
- APGE 2.1B
- IPO Year
- NVCR 2015
- APGE 2023
- Fundamental
- Price
- NVCR $16.69
- APGE $41.96
- Analyst Decision
- NVCR Buy
- APGE Strong Buy
- Analyst Count
- NVCR 6
- APGE 4
- Target Price
- NVCR $32.83
- APGE $91.33
- AVG Volume (30 Days)
- NVCR 1.6M
- APGE 785.6K
- Earning Date
- NVCR 07-24-2025
- APGE 08-11-2025
- Dividend Yield
- NVCR N/A
- APGE N/A
- EPS Growth
- NVCR N/A
- APGE N/A
- EPS
- NVCR N/A
- APGE N/A
- Revenue
- NVCR $621,711,000.00
- APGE N/A
- Revenue This Year
- NVCR $5.56
- APGE N/A
- Revenue Next Year
- NVCR $9.19
- APGE $743.14
- P/E Ratio
- NVCR N/A
- APGE N/A
- Revenue Growth
- NVCR 18.27
- APGE N/A
- 52 Week Low
- NVCR $14.17
- APGE $26.20
- 52 Week High
- NVCR $34.13
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- NVCR 43.44
- APGE 56.93
- Support Level
- NVCR $17.20
- APGE $40.67
- Resistance Level
- NVCR $18.02
- APGE $44.65
- Average True Range (ATR)
- NVCR 1.04
- APGE 2.48
- MACD
- NVCR -0.09
- APGE 0.18
- Stochastic Oscillator
- NVCR 15.51
- APGE 70.41
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.